Categories Health Care, U.S. Markets News

Thailand legalizes medical use of cannabis, opens up a new region for pot stocks

After Uruguay and Canada, Thailand has now amended its drug law to legalize marijuana for medical purposes. However, unlike the other two counties, legalization does not apply to recreational use.

After the parliament voted to push the bill, one of its lawmakers called it a “New Year gift to the Thai people.”

CREDIT: Sharon McCutcheon

Ironically, South East Asia is a region that prescribes the toughest penalties for drug-related offenses. In Indonesia, Singapore, and Malaysia, weed-related offenses may lead up to capital punishment.

This is great news for companies involved in medical marijuana research including Tilray (TLRY), Canopy Growth (CGC), Aphria Inc (APHA), Innovative Industrial Properties (IIPR) and KushCo Holdings (KSHB). The companies currently concentrate most of their in Canada, where marijuana was legalized in October this year.

Shares of most cannabis stocks opened higher on Wednesday during pre-market trading.

The legalization not only opens up a new market for these companies but also a gateway to a much bigger region.

According to the Bangkok Post, pot users will be allowed to carry only prescribed amounts that are required for medical use. The consumers will also need to furnish a recognized certificate to authorities as sale and production of weed will be in a controlled manner.

Aurora Cannabis eyes 130-mn market through Mexican firm acquisition

Research shows that marijuana is effective in pain relief, besides the treatment of nausea caused due to chemotherapy. Clinical studies are underway to study the other medical applications of marijuana.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

Micron Technology (MU) Q3 Earnings: Key financials and quarterly highlights

Micron Technology Inc. (NASDAQ: MU) reported third quarter 2022 earnings results today. Revenue increased 16% year-over-year to $8.64 billion. GAAP net income was $2.63 billion, or $2.34 per share, compared

Constellation Brands (STZ): Earnings beat and share structure revamp put brewer in the spotlight

Shares of Constellation Brands Inc. (NYSE: STZ) were down 4% on Thursday despite the company beating expectations on its first quarter 2023 earnings results. The stock has dropped 7% year-to-date.

Infographic: Key highlights from Constellation Brands (STZ) Q1 2023 earnings results

Constellation Brands, Inc. (NYSE: STZ) reported first quarter 2023 earnings results today. Net sales increased 17% year-over-year to $2.3 billion. Net income attributable to CBI was $390 million, or $2.06

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top